January 4, 2016 - Two Curant Health articles made the list of the "2015: Best of Specialty Pharmacy Times Journal." PCSK9 Inhibitors: Smoothing the path to access and value Three things more "presidential" than simply hammering drug manufacturers on price Curant Health is featured in several sections in the Managed Healthcare Executive "Most Popular Pharmacy" […]
December 24, 2015 - Curant COO, Marc O'Connor, featured in Managed Healthcare Executive - One of the biggest aspects of healthcare reform is the shift to value-focused reimbursement, but Marc O’Connor, chief operating officer for Curant Health, a medication management company says it’s not always clear what that entails. Healthcare organizations, he says, should define […]
Curant COO, Marc O’Connor, was recently featured in Specialty Pharmacy Times in a piece that highlights the futility of presidential candidates focusing strictly on pharmaceutical manufacturers as the primary source of healthcare’s woes. It is true that companies such as Turing Pharmaceutical have the ability to cause a strong negative domino effect on patients with pricing […]
December 10, 2015 - Curant COO, Marc O'Connor, in Specialty Pharmacy Times - A case could be made that, overall, health care has not been a focal point of the respective political parties’ presidential nominee debates or campaigns. The discussion has been much, much more specific, focusing on drug manufacturers. In mid-October, both Hillary Clinton […]
Being diagnosed with an illness such as hepatitis C can be shocking for some, to say the least. Receiving a diagnosis of HIV and hepatitis C co-infection can be life-altering. According to the Centers for Disease Control and Prevention (CDC): 25% of patients living with HIV in the U.S. are co-infected with hepatitis C 80% of […]
Hepatitis C is not a new chronic illness, but many people fail to realize how grave the illness is; on some levels, hepatitis C can be compared to HIV in terms of how serious this illness is. There are some interesting and somewhat shocking statistics you may not know about hepatitis C. An estimated 3.2 […]
As 2015 winds down, this would be an opportune time to look at learnings from the last year within the healthcare industry, as well as the future insights from healthcare stakeholders. Curant Health COO, Marc O’Connor, gives his insights on developments providers, manufacturers and payers have seen this year and where future developments will take them […]
December 9, 2015 - Curant COO, Marc O'Connor, in Managed Healthcare Executive - Unwinding a healthcare system built on decades of fee-for-service delivery will not come easily. Nevertheless, 2015 saw several major healthcare changes that will enable the industry to begin to use value from innovation in technology, pharmaceuticals and clinical care as its defining […]
At the end of 2010, the American South accounted for 45% of the estimated 33,015 new AIDS diagnoses in the 50 states and the District of Columbia, followed by the Northeast (24%), the West (19%), and the Midwest (13%).1 On the front lines of this epidemic, The University of Alabama-Birmingham 1917 Clinic serves more than […]
Recently, there has been buzz on the top therapeutic areas to watch for in the healthcare world in 2016. In a recent edition of Managed Healthcare Executive, Curant COO Marc O’Connor gives his perspective on a few upcoming hot healthcare hot topics for next year. Prominent categories of healthcare quickly becoming the center of attention […]
